Back
Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy
@article{Peisenetal24, title = {Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy}, journal = {PLOS ONE}, volume = {19}, number = {1}, month = jan, year = {2024}, author = {Peisen, F. and Gerken, A. and Dahm, I. and Nikolaou, K. and Eigentler, T. and Amaral, T. and Moltz, J. H. and Othman, A. E. and Gatidis, S.}, doi = {10.1371/journal.pone.0296253}, month_numeric = {1} }
More information